Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1890 2
1891 2
1893 1
1895 1
1896 1
1899 3
1901 2
1907 1
1908 1
1910 3
1911 1
1912 3
1913 1
1914 4
1916 1
1920 1
1921 2
1922 1
1924 2
1925 5
1926 4
1927 1
1928 5
1929 1
1930 2
1931 2
1932 1
1933 2
1934 4
1935 2
1936 1
1938 4
1939 5
1940 3
1941 5
1942 2
1943 2
1944 2
1945 84
1946 565
1947 974
1948 1215
1949 1162
1950 1238
1951 1490
1952 1516
1953 1628
1954 1688
1955 1756
1956 1836
1957 1843
1958 1943
1959 1927
1960 2076
1961 2145
1962 2308
1963 3015
1964 4259
1965 4032
1966 3970
1967 4267
1968 4732
1969 5223
1970 5327
1971 5886
1972 6532
1973 7272
1974 7838
1975 8125
1976 8522
1977 9361
1978 10057
1979 11331
1980 12374
1981 12728
1982 14020
1983 15208
1984 16622
1985 17221
1986 18497
1987 18958
1988 20637
1989 22892
1990 24053
1991 24200
1992 26187
1993 28010
1994 29725
1995 32135
1996 34735
1997 38256
1998 40816
1999 42935
2000 46981
2001 50346
2002 54788
2003 58947
2004 66248
2005 73627
2006 79748
2007 86549
2008 93307
2009 98880
2010 109110
2011 119831
2012 128735
2013 137924
2014 150140
2015 158259
2016 159166
2017 162019
2018 169200
2019 180720
2020 204071
2021 216102
2022 210151
2023 201418
2024 203440
2025 198903
2026 10449

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,644,237 results

Results by year

Filters applied: Full text. Clear all
Page 1
Immuno-oncology-the new paradigm of lung cancer treatment.
Dawe DE, Harlos CH, Juergens RA. Dawe DE, et al. Curr Oncol. 2020 Apr;27(Suppl 2):S78-S86. doi: 10.3747/co.27.5183. Epub 2020 Apr 1. Curr Oncol. 2020. PMID: 32368177 Free PMC article. Review.
Part of that evolution has been the incorporation of immuno-oncology drugs, especially immune checkpoint inhibitors (icis) into multiple therapeutic scenarios. ...Finally, we discuss duration of treatment, special populations, and the future of immuno-oncology for p …
Part of that evolution has been the incorporation of immuno-oncology drugs, especially immune checkpoint inhibitors (icis) into multi …
Use of immuno-oncology in melanoma.
Smylie MG. Smylie MG. Curr Oncol. 2020 Apr;27(Suppl 2):S51-S58. doi: 10.3747/co.27.5135. Epub 2020 Apr 1. Curr Oncol. 2020. PMID: 32368174 Free PMC article. Review.
The "Holy Grail" came with the discovery of immune checkpoints, and the first metastatic melanoma trial to show an improvement in overall survival involved the use of an immune checkpoint inhibitor against ctla-4: ipilimumab. Since then, the field of immuno-oncology has ex …
The "Holy Grail" came with the discovery of immune checkpoints, and the first metastatic melanoma trial to show an improvement in overall su …
Hallmarks of artificial intelligence contributions to precision oncology.
Chang TG, Park S, Schäffer AA, Jiang P, Ruppin E. Chang TG, et al. Nat Cancer. 2025 Mar;6(3):417-431. doi: 10.1038/s43018-025-00917-2. Epub 2025 Mar 7. Nat Cancer. 2025. PMID: 40055572 Free PMC article. Review.
The integration of artificial intelligence (AI) into oncology promises to revolutionize cancer care. In this Review, we discuss ten AI hallmarks in precision oncology, organized into three groups: (1) cancer prevention and diagnosis, encompassing cancer screening, d …
The integration of artificial intelligence (AI) into oncology promises to revolutionize cancer care. In this Review, we discuss ten A …
[Haematology and Oncology - A look back at 150 years].
Hiddemann W. Hiddemann W. Dtsch Med Wochenschr. 2024 Dec;149(24-25):1500-1506. doi: 10.1055/a-2298-0609. Epub 2024 Dec 4. Dtsch Med Wochenschr. 2024. PMID: 39631418 Review. German.
The success story of haematology and oncology extends from Virchow's concept of "cellular pathology" to the possibilities of personalized cancer therapy, which molecular oncology offers today. This article highlights the beginnings and developments of chemotherapy, …
The success story of haematology and oncology extends from Virchow's concept of "cellular pathology" to the possibilities of personal …
Oncology's trial and error: Analysis of the FDA withdrawn accelerated approvals.
Preziosi AJ, Priefer R. Preziosi AJ, et al. Life Sci. 2024 Jun 1;346:122615. doi: 10.1016/j.lfs.2024.122615. Epub 2024 Apr 4. Life Sci. 2024. PMID: 38582392 Review.
With cancer being a leading cause of death, a vast majority of drugs that have been approved/withdrawn from this pathway are indicated within oncology. There are a wide variety of cancer subtypes and therapeutic target sites that these drugs have been evaluated for. Herein …
With cancer being a leading cause of death, a vast majority of drugs that have been approved/withdrawn from this pathway are indicated withi …
ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges.
Zhou Z, Qin P, Cheng X, Shao M, Ren Z, Zhao Y, Li Q, Liu L. Zhou Z, et al. Curr Oncol Rep. 2025 Apr;27(4):336-354. doi: 10.1007/s11912-025-01649-3. Epub 2025 Feb 25. Curr Oncol Rep. 2025. PMID: 39998782 Review.
PURPOSE OF REVIEW: This study aims to systematically review the trajectory of artificial intelligence (AI) development in the medical field, with a particular emphasis on ChatGPT, a cutting-edge tool that is transforming oncology's diagnosis and treatment practices. …
PURPOSE OF REVIEW: This study aims to systematically review the trajectory of artificial intelligence (AI) development in the medical field, …
Common Sense Oncology: Equity, Value, and Outcomes That Matter.
Wilson BE, Sengar M, Tregear M, van der Graaf WTA, Luca Battisti NM, Csaba DL, Soto-Perez-de-Celis E, Gyawali B, Booth CM. Wilson BE, et al. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e100039. doi: 10.1200/EDBK_100039. Am Soc Clin Oncol Educ Book. 2024. PMID: 38788178 Free article. Review.
Moreover, treatments that do provide substantial clinical benefits are not available to many patients globally due to issues with availability and affordability. The Common Sense Oncology's vision is that patients will have access to treatments that provide meaningf …
Moreover, treatments that do provide substantial clinical benefits are not available to many patients globally due to issues with availabili …
Targeting T cell activation in immuno-oncology.
Saibil SD, Ohashi PS. Saibil SD, et al. Curr Oncol. 2020 Apr;27(Suppl 2):S98-S105. doi: 10.3747/co.27.5285. Epub 2020 Apr 1. Curr Oncol. 2020. PMID: 32368179 Free PMC article. Review.
The years since 2009 have seen tremendous progress in unlocking the curative potential of the immune system for the treatment of cancer. Much of that revolution in immuno-oncology has been fueled by the clinical success of immune checkpoint inhibitors, particularly those t …
The years since 2009 have seen tremendous progress in unlocking the curative potential of the immune system for the treatment of cancer. Muc …
3,644,237 results
You have reached the last available page of results. Please see the User Guide for more information.